Last reviewed · How we verify
NCT06083012: COMRADE-AI
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
trial testing Cardiac mapping in Atrial Fibrillation in 186 participants. Participants enrolled and being followed up; not accepting new ones.
27 April 2027
Quick facts
| Lead sponsor | Volta Medical |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 186 |
| Start date | 27 October 2023 |
| Primary completion | 27 April 2027 |
| Estimated completion | 27 April 2027 |
| Sites | 7 locations across France, Germany |
Drugs / interventions tested
- Cardiac mapping
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Atrial Arrhythmia — all drugs for Atrial Arrhythmia →
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
Sponsor
Volta Medical
Who can join
18 and older, any sex, with Atrial Fibrillation or Atrial Arrhythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this Observational Prospective Multi-center Study is to observe the acute and long-term safety and performance outcomes after spatiotemporal dispersion-based AF/AT ablation utilizing the Volta Medical AI software in "real-life" clinical practice, without any imposed clinical workflow. Moreover, this study will allow to collect medico-economic data related to the tailored ablation strategy guided by the Volta Medical AI software.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06083012
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Volta Medical trials
Trials by the same sponsor.
- NCT06825104 — Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation · recruiting
- NCT05477147 — Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion · NA · completed
- NCT05362656 — AutoMatic disPERsion Tagging Function Preliminary Evaluation · NA · completed
- NCT04702451 — Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06083012 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Volta Medical
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06083012.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing